Zengen, Inc.
Records under this name other than patents Zengen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,561,182 | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals Formerly held Term ended Term ended Aug 22, 2025 · From the USPTO record | Term ended | Term ended Aug 22, 2025 | From the USPTO record |
| US 10,398,644 | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films Formerly held Term ended Term ended Nov 12, 2023 · From the USPTO record | Term ended | Term ended Nov 12, 2023 | From the USPTO record |
| US 6,800,291 | Uro-genital condition treatment system Formerly held Term ended Ended no later than Mar 23, 2020 · From the USPTO record | Term ended | Ended no later than Mar 23, 2020 | From the USPTO record |
| US 6,894,028 | Use of KPV tripeptide for dermatological disorders Formerly held Lapsed on the fee record Ended May 17, 2017 · From the USPTO record | Lapsed on the fee record | Ended May 17, 2017 | From the USPTO record |
| US 7,244,710 | Treatment of ophthalmic infections using antimicrobial peptides Formerly held Lapsed on the fee record Ended Jul 17, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2015 | From the USPTO record |
| US 7,232,804 | Use of KPV tripeptide for dermatological disorders Formerly held Lapsed on the fee record Ended Jun 19, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2015 | From the USPTO record |
| US 7,115,574 | System and method for support legacy operating system booting in a legacy-free system Formerly held Lapsed on the fee record Ended Oct 3, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2014 | From the USPTO record |
| US 6,887,846 | Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone Formerly held Lapsed on the fee record Ended May 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2013 | From the USPTO record |
| US 7,402,559 | Composition and method of treatment for urogenital conditions Formerly held Lapsed on the fee record Ended Jul 22, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2012 | From the USPTO record |
| US 7,135,548 | Modified α-MSH peptides and derivatives thereof Lapsed on the fee record Ended Nov 14, 2010 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2010 | From the USPTO record |